Collegium Pharmaceutical, Inc. Interest Expense on Debt
Collegium Pharmaceutical, Inc. (COLL) reported Interest Expense on Debt of $3.50 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2021-11-04
- Collegium Pharmaceutical, Inc. interest expense, debt for the quarter ending 2021-09-30 was $1.17M.
- Collegium Pharmaceutical, Inc. interest expense, debt for the quarter ending 2021-06-30 was $1.17M.
- Collegium Pharmaceutical, Inc. interest expense, debt for the quarter ending 2021-03-31 was $1.17M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month |
|---|---|---|---|
| 2021-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.34M derived: sum of 2 quarters · filed 2021-11-04 | $3.50M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-05 | $2.33M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.17M 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |